+44 1300 500008Journal of Antivirals & Antiretrovirals : Citations & Metrics Report
Articles published in Journal of Antivirals & Antiretrovirals have been cited by esteemed scholars and scientists all around the world. Journal of Antivirals & Antiretrovirals has got h-index 22, which means every article in Journal of Antivirals & Antiretrovirals has got 22 average citations.
Following are the list of articles that have cited the articles published in Journal of Antivirals & Antiretrovirals.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
59 | 57 | 32 | 59 | 77 | 13 | 11 | 20 | 37 | 22 | 37 | 55 | 22 | 12 |
Research, Review articles and Editorials |
1 | 0 | 5 | 42 | 32 | 12 | 10 | 14 | 27 | 21 | 33 | 44 | 21 | 10 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
48 | 57 | 27 | 17 | 45 | 1 | 1 | 6 | 10 | 1 | 4 | 11 | 1 | 2 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 35 | 51 | 125 | 100 | 191 | 0 | 125 | 177 |
Citations received as per Google Scholar, other indexing platforms and portals |
98 | 160 | 172 | 269 | 223 | 172 | 219 | 195 | 170 | 116 | 60 | 36 | 26 | 58 |
| Journal total citations count | 2004 |
| Journal impact factor | 5.32 |
| Journal 5 years impact factor | 5.62 |
| Journal cite score | 5.3 |
| Journal h-index | 22 |
| Journal h-index since 2019 | 17 |
Important citations (1101)
Palestinian strategies, guidelines, and challenges in the treatment and management of coronavirus disease-2019 (covid-19) |
|
What we have learned from the covid-19 pandemic: time to think outside the box, maybe far outside |
|
What we have learned from the covid-19 pandemic: time to think outside the box, maybe far outside |
|
Novel coronavirus (covid-19) infection: what a doctor on the frontline needs to know. |
|
Druggable targets of sars-cov-2 and treatment opportunities for covid-19. |
|
Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019 |
|
Cardiovascular implications and therapeutic considerations in covid-19 infection |
|
Implications of antibiotics use during the covid-19 pandemic: present and future. |
|
recent biotechnological approaches for treatment of novel covid-19: from bench to clinical trial. |
|
Azithromycin and covid-19: prompt early use at first signs of this infection in adults and children, an approach worthy of consideration. |
|
inhibitory activity of hydroxychloroquine on covid-19 main protease: an insight from md-simulation studies |
|
azithromycin in covid-19 patients: pharmacological mechanism, clinical evidence and prescribing guidelines. |
|
should azithromycin be used to treat covid-19? a rapid review. |
|
Macrolide treatment for covid-19: will this be the way forward? |
|
The management of surgical patients in the emergency setting during covid-19 pandemic: the wses position paper |
|
Safety and effectiveness of azithromycin in patients with covid-19: an open-label randomised trial. |
|
novel insights into the treatment of sars-cov-2 infection: an overview of current clinical trials. |
|
Ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of sars-cov-2. |
|
Covid-19: present and future challenges for dental practice. |
|
Covid-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection? |
|